title: [Fibrinolysis: indications in ophthalmology].
abstract: The ability to realize a microcatheter urokinase infusion in central retinal artery occlusion open new ways in therapy. It provides opportunity to realize in situ thrombolysis without well-known systemic side-effects. If started during the first hours after the occlusion, that therapy could be successful and give good visual prognosis.
authors.affiliation: CHU, Sart-Tilman, Liège, Belgique.
authors.forename: F
authors.initials: F
authors.lastname: Van Cauwenberge
mesh_terms: D000792:Angiography / Q000379:methods; D006801:Humans; D007263:Infusions, Parenteral; D009880:Ophthalmic Artery / Q000000981:diagnostic imaging; D015356:Retinal Artery Occlusion / Q000188:drug therapy*; D014568:Urokinase-Type Plasminogen Activator / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D014568:Urokinase-Type Plasminogen Activator
vernacular_title: Fibrinolyse: indications en ophtalmologie.